Intervention Protocol

Very early discharge versus early discharge versus non-early discharge in pediatric cancer patients with febrile neutropenia

  1. Esther M te Poele*,
  2. Wim JE Tissing,
  3. Eveline SJM de Bont

Editorial Group: Cochrane Childhood Cancer Group

Published Online: 17 FEB 2010

DOI: 10.1002/14651858.CD008382


How to Cite

te Poele EM, Tissing WJE, de Bont ESJM. Very early discharge versus early discharge versus non-early discharge in pediatric cancer patients with febrile neutropenia (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 2. Art. No.: CD008382. DOI: 10.1002/14651858.CD008382.

Author Information

  1. Beatrix Children's Hospital, UMCG, Pediatric Oncology/Hematology, Groningen, Netherlands

*Esther M te Poele, Pediatric Oncology/Hematology, Beatrix Children's Hospital, UMCG, PO Box 30.001, Groningen, 9700 RB, Netherlands. e.m.te.poele@bkk.umcg.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 17 FEB 2010

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary aim of the review is to evaluate whether (very) early discharge from in-hospital treatment, for a selected group of patients, is not inferior to non-early discharge from in-hospital treatment in pediatric cancer patients with febrile neutropenia, with regard to rehospitalization and death. Moreover, we will look at quality of life, costs, and duration of treatment as secondary outcomes. We will analyze these outcomes in all pediatric cancer patients as well as in various subgroups.